Let’s get down to it: why should investors consider pharma stocks? Primarily, it comes down to the permanence of the underlying narrative. So long as humans are afflicted by various diseases, there will be a need for advanced pharmaceutical solutions. Therefore, money has been flowing into the broader biotechnology space and that will probably not fade anytime soon.The second reason? Pure numbers. According to Grand View Research, the global biotech market reached a valuation of $1.55 trillion last year. Be ...